Found: 8
Select item for more details and to access through your institution.
<sup>89</sup>Zr‐ImmunoPET companion diagnostics and their impact in clinical drug development.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2018, v. 61, n. 9, p. 727, doi. 10.1002/jlcr.3605
- By:
- Publication type:
- Article
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer.
- Published in:
- Science Signaling, 2014, v. 7, n. 318, p. 1, doi. 10.1126/scisignal.2005125
- By:
- Publication type:
- Article
Monitoring Src status after dasatinib treatment in HER2+ breast cancer with <sup>89</sup>Zr-trastuzumab PET imaging.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 283, p. 1, doi. 10.1126/scitranslmed.aaa4442
- By:
- Publication type:
- Article
Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1876, doi. 10.2967/jnumed.113.119867
- By:
- Publication type:
- Article
Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with <sup>18</sup>F-FDG and <sup>89</sup>Zr-Trastuzumab PET.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 6, p. 936, doi. 10.2967/jnumed.112.110239
- By:
- Publication type:
- Article
Targeting Gallium to Cancer Cells through the Folate Receptor.
- Published in:
- Drug Target Insights, 2008, n. 3, p. 13, doi. 10.4137/DTI.S651
- By:
- Publication type:
- Article
Targeting the Folate Receptor (FR): Imaging and Cytotoxicity of Re<sup>I</sup> Conjugates in FR-Overexpressing Cancer Cells.
- Published in:
- ChemMedChem, 2008, v. 3, n. 9, p. 1387, doi. 10.1002/cmdc.200800125
- By:
- Publication type:
- Article